• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
Menu
GOVPH
  • Home
  • Our Programs
    • COVID 19
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
      • Active Drug Safety Monitoring and Management (aDSM) Program
  • About Us
    • The Pharmaceutical Division
    • Calendar of Events
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches
    • Official Publications
      • Drug Price Reference Index Booklet
      • National Antibiotic Guidelines
      • The Philippine Action Plan to Combat Antimicrobial Resistance 2019-2023
      • Philippine National Formulary
      • Progress Report
  • Media Gallery
  • Links
  • AUXILIARY MENU
  • GOVPH
  • Home
  • Our Programs
    • COVID 19
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
      • Active Drug Safety Monitoring and Management (aDSM) Program
  • About Us
    • The Pharmaceutical Division
    • Calendar of Events
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches
    • Official Publications
      • Drug Price Reference Index Booklet
      • National Antibiotic Guidelines
      • The Philippine Action Plan to Combat Antimicrobial Resistance 2019-2023
      • Philippine National Formulary
      • Progress Report
  • Media Gallery
  • Links
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer

Value Added Tax (VAT) Exempt Sales of Drugs and Medicines Prescribed for Diabetes, Hypertension and High Cholesterol Under Train Law

English Filipino English Filipino Related Posts Value Added Tax (VAT) Exemption on the Sale of Drugs 07 Oct 2020 Electronic Drug Price Monitoring System 21 Sep 2020 Maximum Retail Price continue reading : Value Added Tax (VAT) Exempt Sales of Drugs and Medicines Prescribed for Diabetes, Hypertension and High Cholesterol Under Train Law